top of page
Director: Jenny Munson, Ph.D.
Blood perfusion to a glioma
1/3
Using flow to treat disease.
Targeting cancer at the tissue level.
Once we know what's wrong in the tumor microenvironment, we can target nanoparticle therapeutics to the tumor and fix it. Diagnostic tools for assessing the microenvironment without need for tissue samples can close the loop on our personalized microenvironment therapy.
Team members:
Monet Roberts, Ph.D.
Peng Jin, Ph.D.
Rhea John
Joseph Owens
Basic screening system
Pentachrome stained human glioma
Basic screening system
1/2
Patient-specific models of cancer
Predicting therapeutic response
one patient at a time
Therapeutic selection is still poorly defined for most cancers. By developing patient-derived and designed systems in which to test therapeutics before they're given to the patient, we help oncologists make the best decisions.
Team members:
Jenn Hammel
Kinsley Tate
Rhea John
Samantha Howerton
​
bottom of page